{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:51:07Z","timestamp":1792122667371,"version":"4.4.0"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07244-1","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:51:29Z","timestamp":1761742289000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Immunometabolic reprogramming in lung cancer: interplay between immune and stem-like cells in immune checkpoint inhibitor resistance"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8397-1691","authenticated-orcid":false,"given":"Ji-Yong","family":"Sung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eui Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"issue":"1","key":"7244_CR1","doi-asserted-by":"publisher","first-page":"2457797","DOI":"10.1080\/2162402X.2025.2457797","volume":"14","author":"Q Wang","year":"2025","unstructured":"Wang Q, et al. Metabolic heterogeneity in tumor cells impacts immunology in lung squamous cell carcinoma. Oncoimmunology. 2025;14(1):2457797.","journal-title":"Oncoimmunology"},{"issue":"1","key":"7244_CR2","first-page":"129","volume":"5","author":"L Yunchang","year":"2022","unstructured":"Yunchang L, et al. Resistance to immune checkpoint inhibitors in KRAS-mutant non-small cell lung cancer. Cancer Drug Resist. 2022;5(1):129\u201346.","journal-title":"Cancer Drug Resist"},{"issue":"2","key":"7244_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3892\/ol.2022.13407","volume":"24","author":"X Li","year":"2022","unstructured":"Li X, et al. Tumor metabolic reprogramming in lung cancer progression. Oncol Lett. 2022;24(2):287.","journal-title":"Oncol Lett"},{"issue":"1","key":"7244_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12943-024-01981-5","volume":"23","author":"Q Dang","year":"2024","unstructured":"Dang Q, et al. Cancer immunometabolism: Advent, challenges, and perspective. Mol Cancer. 2024;23(1):72.","journal-title":"Mol Cancer"},{"key":"7244_CR5","doi-asserted-by":"publisher","first-page":"175883592093790","DOI":"10.1177\/1758835920937902","volume":"12","author":"RJ Walsh","year":"2020","unstructured":"Walsh RJ, Soo RA. Resistance to immune checkpoint inhibitors in non-small cell lung cancer: Biomarkers and therapeutic strategies. Ther Adv Med Oncol. 2020;12:1758835920937902.","journal-title":"Ther Adv Med Oncol"},{"issue":"6","key":"7244_CR6","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/cac2.12285","volume":"42","author":"JY Sung","year":"2022","unstructured":"Sung JY, Cheong JH. Intercellular communications and metabolic reprogramming as new predictive markers for immunotherapy responses in gastric cancer. Cancer Commun (lond). 2022;42(6):572\u201375.","journal-title":"Cancer Commun (lond)"},{"key":"7244_CR7","doi-asserted-by":"crossref","unstructured":"Wen GM, Xu XY, Xia P. Metabolism in cancer stem cells: Targets for clinical treatment. Cells. 2022;11(23).","DOI":"10.3390\/cells11233790"},{"key":"7244_CR8","doi-asserted-by":"crossref","unstructured":"Sung JY, Cheong JH. Pan-Cancer analysis reveals distinct metabolic reprogramming in different epithelial-mesenchymal transition activity States. Cancers (basel). 2021;13(8).","DOI":"10.3390\/cancers13081778"},{"key":"7244_CR9","doi-asserted-by":"crossref","unstructured":"Sung JY, Cheong JH. New Immunometabolic strategy based on cell type-specific metabolic reprogramming in the tumor immune Microenvironment. cells. 2022;11(5):768.","DOI":"10.3390\/cells11050768"},{"key":"7244_CR10","first-page":"- 2022","volume":"13","author":"M Zhu","year":"2022","unstructured":"Zhu M, et al. Clinical significance and immunometabolism landscapes of a novel recurrence-associated lipid metabolism signature in early-stage lung adenocarcinoma: A comprehensive analysis. Front Immunol. 2022;13:- 2022.","journal-title":"Front Immunol"},{"key":"7244_CR11","doi-asserted-by":"publisher","first-page":"1129465","DOI":"10.3389\/fimmu.2023.1129465","volume":"14","author":"S Zhou","year":"2023","unstructured":"Zhou S, Yang H. Immunotherapy resistance in non-small-cell lung cancer: From mechanism to clinical strategies. Front Immunol. 2023;14:1129465.","journal-title":"Front Immunol"},{"key":"7244_CR12","doi-asserted-by":"publisher","first-page":"- 2024","DOI":"10.3389\/fphar.2024.1516650","volume":"15","author":"Q Huang","year":"2024","unstructured":"Huang Q, et al. Metabolic reprogramming in lung cancer and its clinical implication. Front Pharmacol. 2024;15:- 2024.","journal-title":"Front Pharmacol"},{"key":"7244_CR13","doi-asserted-by":"crossref","unstructured":"Hao ZN, et al. Lactate and lactylation: Dual regulators of T-Cell-mediated tumor immunity and immunotherapy. Biomolecules. 2024;14(12).","DOI":"10.3390\/biom14121646"},{"key":"7244_CR14","doi-asserted-by":"publisher","first-page":"1101433","DOI":"10.3389\/fimmu.2023.1101433","volume":"14","author":"L Barbieri","year":"2023","unstructured":"Barbieri L, et al. Lactate exposure shapes the metabolic and transcriptomic profile of CD8+ T cells. Front Immunol. 2023;14:1101433.","journal-title":"Front Immunol"},{"issue":"1","key":"7244_CR15","doi-asserted-by":"publisher","first-page":"9394","DOI":"10.1038\/s41467-024-53593-8","volume":"15","author":"H Shen","year":"2024","unstructured":"Shen H, et al. HIF1\u03b1-regulated glycolysis promotes activation-induced cell death and IFN-\u03b3 induction in hypoxic T cells. Nat Commun. 2024;15(1):9394.","journal-title":"Nat Commun"},{"issue":"1","key":"7244_CR16","doi-asserted-by":"publisher","first-page":"6858","DOI":"10.1038\/s41467-023-42634-3","volume":"14","author":"H Wu","year":"2023","unstructured":"Wu H, et al. Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1\u03b1-mediated glycolytic reprogramming. Nat Commun. 2023;14(1):6858.","journal-title":"Nat Commun"},{"issue":"2","key":"7244_CR17","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.immuni.2016.07.008","volume":"45","author":"B Bengsch","year":"2016","unstructured":"Bengsch B, et al. Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an Early Driver of CD8(+) T cell exhaustion. Immunity. 2016;45(2):358\u201373.","journal-title":"Immunity"},{"issue":"2","key":"7244_CR18","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.immuni.2016.07.009","volume":"45","author":"NE Scharping","year":"2016","unstructured":"Scharping NE, et al. The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction. Immunity. 2016;45(2):374\u201388.","journal-title":"Immunity"},{"issue":"4","key":"7244_CR19","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.cell.2017.04.004","volume":"169","author":"MD Buck","year":"2017","unstructured":"Buck MD, et al. Metabolic instruction of immunity. Cell. 2017;169(4):570\u201386.","journal-title":"Cell"},{"issue":"6","key":"7244_CR20","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","volume":"25","author":"A Angelin","year":"2017","unstructured":"Angelin A, et al. Foxp3 reprograms T cell metabolism to function in Low-Glucose, high-lactate environments. Cell Metab. 2017;25(6):1282\u201393.e7.","journal-title":"Cell Metab"},{"issue":"7851","key":"7244_CR21","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","volume":"591","author":"MJ Watson","year":"2021","unstructured":"Watson MJ, et al. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature. 2021;591(7851):645\u201351.","journal-title":"Nature"},{"key":"7244_CR22","doi-asserted-by":"publisher","first-page":"1114582","DOI":"10.3389\/fimmu.2023.1114582","volume":"14","author":"CK Keerthana","year":"2023","unstructured":"Keerthana CK, et al. The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment. Front Immunol. 2023;14:1114582.","journal-title":"Front Immunol"},{"issue":"5899","key":"7244_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1126\/science.1160062","volume":"322","author":"K Wing","year":"2008","unstructured":"Wing K, et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science. 2008;322(5899):271\u201375.","journal-title":"Science"},{"issue":"6","key":"7244_CR24","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1084\/jem.20062512","volume":"204","author":"S Deaglio","year":"2007","unstructured":"Deaglio S, et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med. 2007;204(6):1257\u201365.","journal-title":"J Exp Med"},{"issue":"24","key":"7244_CR25","doi-asserted-by":"publisher","first-page":"6102","DOI":"10.1182\/blood-2008-12-195354","volume":"113","author":"MD Sharma","year":"2009","unstructured":"Sharma MD, et al. Indoleamine 2, 3-dioxygenase controls conversion of Foxp3+ tregs to TH17-like cells in tumor-draining lymph nodes. Blood. 2009;113(24):6102\u201311.","journal-title":"Blood"},{"issue":"1","key":"7244_CR26","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/s42003-021-02721-x","volume":"4","author":"LB Jarvis","year":"2021","unstructured":"Jarvis LB, et al. Therapeutically expanded human regulatory T-cells are super-suppressive due to HIF1A induced expression of CD73. Commun Biol. 2021;4(1):1186.","journal-title":"Commun Biol"},{"issue":"6","key":"7244_CR27","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","volume":"185","author":"JD Mezrich","year":"2010","unstructured":"Mezrich JD, et al. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. The J Immunol. 2010;185(6):3190\u201398.","journal-title":"The J Immunol"},{"issue":"8","key":"7244_CR28","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1084\/jem.20042028","volume":"201","author":"V Bronte","year":"2005","unstructured":"Bronte V, et al. Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers. J Exp Med. 2005;201(8):1257\u201368.","journal-title":"J Exp Med"},{"issue":"16","key":"7244_CR29","doi-asserted-by":"publisher","first-page":"5839","DOI":"10.1158\/0008-5472.CAN-04-0465","volume":"64","author":"PC Rodriguez","year":"2004","unstructured":"Rodriguez PC, et al. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res. 2004;64(16):5839\u201349.","journal-title":"Cancer Res"},{"issue":"11","key":"7244_CR30","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1158\/2326-6066.CIR-15-0036","volume":"3","author":"F Hossain","year":"2015","unstructured":"Hossain F, et al. Inhibition of fatty acid oxidation modulates immunosuppressive functions of myeloid-derived suppressor cells and enhances cancer therapies. Cancer Immunol Res. 2015;3(11):1236\u201347.","journal-title":"Cancer Immunol Res"},{"issue":"7635","key":"7244_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature20791","volume":"541","author":"G Pascual","year":"2017","unstructured":"Pascual G, et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature. 2017;541(7635):41\u201345.","journal-title":"Nature"},{"issue":"9","key":"7244_CR32","doi-asserted-by":"publisher","first-page":"5693","DOI":"10.4049\/jimmunol.0900092","volume":"182","author":"CA Corzo","year":"2009","unstructured":"Corzo CA, et al. Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. The J Immunol. 2009;182(9):5693\u2013701.","journal-title":"The J Immunol"},{"issue":"7","key":"7244_CR33","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nm1609","volume":"13","author":"S Nagaraj","year":"2007","unstructured":"Nagaraj S, et al. Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat Med. 2007;13(7):828\u201335.","journal-title":"Nat Med"},{"issue":"9","key":"7244_CR34","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/ni.2956","volume":"15","author":"S-C-C Huang","year":"2014","unstructured":"Huang S-C-C, et al. Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages. Nat Immunol. 2014;15(9):846\u201355.","journal-title":"Nat Immunol"},{"key":"7244_CR35","doi-asserted-by":"crossref","unstructured":"Eisinger S, et al. Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells. Proceedings of the National Academy of Sciences. 2020): 32005\u201316,. 117(50.","DOI":"10.1073\/pnas.2015343117"},{"issue":"2","key":"7244_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1084\/jem.20140559","volume":"212","author":"T Voron","year":"2015","unstructured":"Voron T, et al. VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors. J Exp Med. 2015;212(2):139\u201348.","journal-title":"J Exp Med"},{"issue":"11","key":"7244_CR37","doi-asserted-by":"publisher","first-page":"5137","DOI":"10.1172\/JCI96268","volume":"128","author":"P Jayaprakash","year":"2018","unstructured":"Jayaprakash P, et al. Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy. J. Clin. Invest. 2018;128(11):5137\u201349.","journal-title":"J. Clin. Invest"},{"key":"7244_CR38","doi-asserted-by":"crossref","unstructured":"Mertens C, et al. The macrophage iron signature in health and disease. Int J Mol Sci. 2021;22(16).","DOI":"10.3390\/ijms22168457"},{"issue":"3","key":"7244_CR39","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/eji.200939889","volume":"40","author":"S Recalcati","year":"2010","unstructured":"Recalcati S, et al. Differential regulation of iron homeostasis during human macrophage polarized activation. Eur J Immunol 2010;40(3):824\u201335.","journal-title":"Eur. J. Immunol"},{"issue":"1","key":"7244_CR40","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s12967-021-03034-7","volume":"19","author":"JL Sun","year":"2021","unstructured":"Sun JL, et al. Tumor cell-imposed iron restriction drives immunosuppressive polarization of tumor-associated macrophages. J Transl Med. 2021;19(1):347.","journal-title":"J Transl Med"},{"key":"7244_CR41","doi-asserted-by":"crossref","unstructured":"Wang S, et al. Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance. npj precision oncology. 2024;8(1):31.","DOI":"10.1038\/s41698-024-00522-z"},{"issue":"8","key":"7244_CR42","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nm.2172","volume":"16","author":"DL Herber","year":"2010","unstructured":"Herber DL, et al. Lipid accumulation and dendritic cell dysfunction in cancer. Nat Med. 2010;16(8):880\u201386.","journal-title":"Nat Med"},{"issue":"1","key":"7244_CR43","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1038\/s41467-017-02186-9","volume":"8","author":"F Veglia","year":"2017","unstructured":"Veglia F, et al. Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer. Nat Commun. 2017;8(1):2122.","journal-title":"Nat Commun"},{"issue":"4","key":"7244_CR44","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/ni.2833","volume":"15","author":"B Everts","year":"2014","unstructured":"Everts B, et al. TLR-driven early glycolytic reprogramming via the kinases TBK1-iKK\u025b supports the anabolic demands of dendritic cell activation. Nat Immunol. 2014;15(4):323\u201332.","journal-title":"Nat Immunol"},{"issue":"23","key":"7244_CR45","doi-asserted-by":"publisher","first-page":"4742","DOI":"10.1182\/blood-2009-10-249540","volume":"115","author":"CM Krawczyk","year":"2010","unstructured":"Krawczyk CM, et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood. 2010;115(23):4742\u201349.","journal-title":"Blood"},{"issue":"5","key":"7244_CR46","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s12195-020-00652-x","volume":"13","author":"R Sangsuwan","year":"2020","unstructured":"Sangsuwan R, et al. Lactate Exposure Promotes Immunosuppressive Phenotypes in Innate Immune Cells. Cell Mol Bioeng. 2020;13(5):541\u201357.","journal-title":"Cell Mol Bioeng"},{"issue":"5","key":"7244_CR47","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","volume":"24","author":"A Brand","year":"2016","unstructured":"Brand A, et al. LDHA-Associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab. 2016;24(5):657\u201371.","journal-title":"Cell Metab"},{"issue":"6","key":"7244_CR48","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","volume":"162","author":"C-H Chang","year":"2015","unstructured":"Chang C-H, et al. Metabolic competition in the tumor microenvironment is a Driver of cancer progression. Cell. 2015;162(6):1229\u201341.","journal-title":"Cell"},{"key":"7244_CR49","doi-asserted-by":"publisher","first-page":"- 2020","DOI":"10.3389\/fimmu.2020.00868","volume":"11","author":"TA Waldmann","year":"2020","unstructured":"Waldmann TA, et al. IL-15 in the combination immunotherapy of cancer. Front Immunol. 2020;11:- 2020.","journal-title":"Front Immunol"},{"issue":"10","key":"7244_CR50","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nrc.2016.71","volume":"16","author":"BJ Altman","year":"2016","unstructured":"Altman BJ, Stine ZE, Dang CV. From Krebs to clinic: Glutamine metabolism to cancer therapy. Nat Rev Cancer. 2016;16(10):619\u201334.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"7244_CR51","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13046-024-02994-0","volume":"43","author":"B Wang","year":"2024","unstructured":"Wang B, et al. A glutamine tug-of-war between cancer and immune cells: Recent advances in unraveling the ongoing battle. J Exp Clin Cancer Res. 2024;43(1):74.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"7244_CR52","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.cmet.2022.04.003","volume":"34","author":"SA Best","year":"2022","unstructured":"Best SA, et al. Glutaminase inhibition impairs CD8 T cell activation in STK11-\/Lkb1-deficient lung cancer. Cell Metab. 2022;34(6):874\u201387.e6.","journal-title":"Cell Metab"},{"key":"7244_CR53","doi-asserted-by":"publisher","first-page":"- 2022","DOI":"10.3389\/fimmu.2022.1023023","volume":"13","author":"CL Lorentzen","year":"2022","unstructured":"Lorentzen CL, et al. Arginase-1 targeting peptide vaccine in patients with metastatic solid tumors - a phase I trial. Front Immunol. 2022;13:- 2022.","journal-title":"Front Immunol"},{"issue":"3 Suppl","key":"7244_CR54","first-page":"958s","volume":"7","author":"F Taheri","year":"2001","unstructured":"Taheri F, et al. L-Arginine regulates the expression of the T-cell receptor zeta chain (CD3zeta) in Jurkat cells. Clin Cancer Res. 2001;7(3 Suppl):958s\u201365s.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"7244_CR55","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.4161\/auto.21315","volume":"8","author":"R Garc\u00eda-Navas","year":"2012","unstructured":"Garc\u00eda-Navas R, Munder M, Mollinedo F. Depletion of L-arginine induces autophagy as a cytoprotective response to endoplasmic reticulum stress in human T lymphocytes. Autophagy. 2012;8(11):1557\u201376.","journal-title":"Autophagy"},{"issue":"1","key":"7244_CR56","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12964-020-00653-3","volume":"18","author":"Q Dong","year":"2020","unstructured":"Dong Q, et al. Lactate-induced MRP1 expression contributes to metabolism-based etoposide resistance in non-small cell lung cancer cells. Cell Commun Signaling. 2020;18(1):167.","journal-title":"Cell Commun Signaling"},{"issue":"12","key":"7244_CR57","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.3390\/biom14121646","volume":"14","author":"Z-N Hao","year":"2024","unstructured":"Hao Z-N, et al. Lactate and lactylation: Dual regulators of T-Cell-mediated tumor immunity and immunotherapy. Biomolecules. 2024;14(12):1646.","journal-title":"Biomolecules"},{"issue":"1","key":"7244_CR58","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12964-025-02069-3","volume":"23","author":"Q Xu","year":"2025","unstructured":"Xu Q, et al. Intrinsic STING of CD8 + T cells regulates self-metabolic reprogramming and memory to exert anti-tumor effects. Cell Commun Signaling. 2025;23(1):99.","journal-title":"Cell Commun Signaling"},{"issue":"6","key":"7244_CR59","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.cmet.2020.10.013","volume":"32","author":"SK Varanasi","year":"2020","unstructured":"Varanasi SK, Kumar SV, Rouse BT. Determinants of tissue-specific metabolic adaptation of T cells. Cell Metab. 2020;32(6):908\u201319.","journal-title":"Cell Metab"},{"key":"7244_CR60","doi-asserted-by":"publisher","first-page":"1082195","DOI":"10.3389\/fcell.2022.1082195","volume":"10","author":"MK Blake","year":"2022","unstructured":"Blake MK, O\u2019Connell P, Aldhamen YA. Fundamentals to therapeutics: Epigenetic modulation of CD8(+) T cell exhaustion in the tumor microenvironment. Front Cell Dev Biol 2022;10:1082195.","journal-title":"Front. Cell Dev. Biol"},{"key":"7244_CR61","doi-asserted-by":"crossref","unstructured":"Erra D\u00edaz F, Dantas E, Geffner J. Unravelling the interplay between extracellular acidosis and immune cells. Mediators Inflamm; 2018; 2018. p. 1218297.","DOI":"10.1155\/2018\/1218297"},{"issue":"1","key":"7244_CR62","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/imr.12432","volume":"272","author":"A Alloatti","year":"2016","unstructured":"Alloatti A, et al. Dendritic cell maturation and cross-presentation: timing matters! Immunol Rev. 2016;272(1):97\u2013108.","journal-title":"Immunol Rev"},{"key":"7244_CR63","doi-asserted-by":"publisher","first-page":"691134","DOI":"10.3389\/fimmu.2021.691134","volume":"12","author":"I Manoharan","year":"2021","unstructured":"Manoharan I, et al. Lactate-dependent regulation of immune responses by dendritic cells and macrophages. Front Immunol. 2021;12:691134.","journal-title":"Front Immunol"},{"key":"7244_CR64","doi-asserted-by":"crossref","unstructured":"Yasuda T, et al. Peripheral immune system modulates purkinje cell degeneration in niemann-pick disease type C1. Life Sci Alliance. 2023;6(9).","DOI":"10.26508\/lsa.202201881"},{"key":"7244_CR65","doi-asserted-by":"crossref","unstructured":"Zhou J, et al. Lactate supports Treg function and immune balance via MGAT1 effects on N-glycosylation in the mitochondria. J Clin Invest 2024;134(20).","DOI":"10.1172\/JCI175897"},{"issue":"5","key":"7244_CR66","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/sji.12162","volume":"79","author":"S Mia","year":"2014","unstructured":"Mia S, et al. An optimized protocol for human M2 macrophages using M-CSF and IL-4\/IL-10\/TGF-\u03b2 yields a dominant immunosuppressive phenotype. Scand J Immunol. 2014;79(5):305\u201314.","journal-title":"Scand J Immunol"},{"key":"7244_CR67","doi-asserted-by":"crossref","unstructured":"Zeng Y, et al. Influence of lactate in resistance to anti\u2011PD\u20111\/PD\u2011L1 therapy: Mechanisms and clinical applications (review). Mol Med Rep. 2025;31(2).","DOI":"10.3892\/mmr.2024.13413"},{"issue":"1","key":"7244_CR68","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12935-020-01719-5","volume":"21","author":"A Emami Nejad","year":"2021","unstructured":"Emami Nejad A, et al. The role of hypoxia in the tumor microenvironment and development of cancer stem cell: A novel approach to developing treatment. Cancer Cell Int. 2021;21(1):62.","journal-title":"Cancer Cell Int"},{"issue":"3","key":"7244_CR69","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1002\/med.21771","volume":"41","author":"L You","year":"2021","unstructured":"You L, et al. The role of hypoxia-inducible factor 1 in tumor immune evasion. Med Res Rev. 2021;41(3):1622\u201343.","journal-title":"Med Res Rev"},{"issue":"8","key":"7244_CR70","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.freeradbiomed.2004.12.004","volume":"38","author":"TM Asikainen","year":"2005","unstructured":"Asikainen TM, et al. Stimulation of HIF-1\u03b1, HIF-2\u03b1, and VEGF by prolyl 4-hydroxylase inhibition in human lung endothelial and epithelial cells. Free Radical Biol Med. 2005;38(8):1002\u201313.","journal-title":"Free Radical Biol Med"},{"issue":"1","key":"7244_CR71","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13045-021-01102-5","volume":"14","author":"X-C Ding","year":"2021","unstructured":"Ding X-C, et al. The relationship between expression of PD-L1 and HIF-1\u03b1 in glioma cells under hypoxia. J Hematol Oncol. 2021;14(1):92.","journal-title":"J Hematol Oncol"},{"issue":"5","key":"7244_CR72","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/eji.201142053","volume":"42","author":"T K\u00f6hler","year":"2012","unstructured":"K\u00f6hler T, et al. Influence of hypoxia-inducible factor 1\u03b1 on dendritic cell differentiation and migration. Eur J Immunol 2012;42(5):1226\u201336.","journal-title":"Eur. J. Immunol"},{"key":"7244_CR73","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","volume":"63","author":"R Tokunaga","year":"2018","unstructured":"Tokunaga R, et al. CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - a target for novel cancer therapy. Cancer Treat Rev. 2018;63:40\u201347.","journal-title":"Cancer Treat Rev"},{"key":"7244_CR74","doi-asserted-by":"crossref","unstructured":"Korbecki J, et al. The effect of hypoxia on the expression of CXC Chemokines and CXC chemokine receptors-a review of literature. Int J Mol Sci. 2021;22(2).","DOI":"10.3390\/ijms22020843"},{"issue":"4","key":"7244_CR75","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nri3818","volume":"15","author":"PA Roche","year":"2015","unstructured":"Roche PA, Furuta K. The ins and outs of MHC class II-mediated antigen processing and presentation. Nat Rev Immunol. 2015;15(4):203\u201316.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"7244_CR76","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41420-024-02278-8","volume":"11","author":"N Chandimali","year":"2025","unstructured":"Chandimali N, et al. Free radicals and their impact on health and antioxidant defenses: A review. Cell Death Discov. 2025;11(1):19.","journal-title":"Cell Death Discov"},{"key":"7244_CR77","doi-asserted-by":"publisher","first-page":"155747","DOI":"10.1016\/j.metabol.2023.155747","volume":"151","author":"R Shah","year":"2024","unstructured":"Shah R, et al. The role of ROS in tumor infiltrating immune cells and cancer immunotherapy. Metabolism. 2024;151:155747.","journal-title":"Metabolism"},{"key":"7244_CR78","doi-asserted-by":"crossref","unstructured":"Lendeckel U, Wolke C. Redox-regulation in cancer stem cells. Biomedicines. 2022;10(10).","DOI":"10.3390\/biomedicines10102413"},{"issue":"1","key":"7244_CR79","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13045-025-01684-4","volume":"18","author":"T Shang","year":"2025","unstructured":"Shang T, et al. Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance. J Hematol Oncol. 2025;18(1):32.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"7244_CR80","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12943-023-01748-4","volume":"22","author":"B Wu","year":"2023","unstructured":"Wu B, et al. Cross-talk between cancer stem cells and immune cells: Potential therapeutic targets in the tumor immune microenvironment. Mol Cancer. 2023;22(1):38.","journal-title":"Mol Cancer"},{"issue":"2","key":"7244_CR81","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","volume":"38","author":"JD Hayes","year":"2020","unstructured":"Hayes JD, Dinkova-Kostova AT, Tew KD. Oxidative stress in cancer. Cancer Cell. 2020;38(2):167\u201397.","journal-title":"Cancer Cell"},{"issue":"8","key":"7244_CR82","doi-asserted-by":"publisher","first-page":"e 1347","DOI":"10.1002\/ctm2.1347","volume":"13","author":"JY Sung","year":"2023","unstructured":"Sung JY, Cheong JH. Gene signature related to cancer stem cells and fibroblasts of stem-like gastric cancer predicts immunotherapy response. Clin Transl Med. 2023;13(8):e 1347.","journal-title":"Clin Transl Med"},{"issue":"12","key":"7244_CR83","doi-asserted-by":"publisher","first-page":"e70079","DOI":"10.1002\/ctm2.70079","volume":"14","author":"JY Sung","year":"2024","unstructured":"Sung JY, et al. A subtype of cancer-associated fibroblast expressing syndecan-2 (SDC2) predicts survival and immune checkpoint inhibitor response in gastric cancer. Clin Transl Med. 2024;14(12):e70079.","journal-title":"Clin Transl Med"},{"key":"7244_CR84","doi-asserted-by":"crossref","unstructured":"Phi LTH, et al. Cancer stem cells (CSCs) in drug resistance and their Therapeutic implications in cancer treatment. Stem Cells Int. 2018; 2018. p. 5416923.","DOI":"10.1155\/2018\/5416923"},{"key":"7244_CR85","doi-asserted-by":"crossref","unstructured":"Mladinich M, Ruan D, Chan CH. Tackling cancer stem cells via inhibition of EMT transcription factors. Stem Cells Int. 2016; 2016. p. 5285892.","DOI":"10.1155\/2016\/5285892"},{"issue":"6","key":"7244_CR86","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.3390\/cancers14061438","volume":"14","author":"JY Sung","year":"2022","unstructured":"Sung JY, Cheong JH. The matrisome is associated with metabolic reprograming in stem-like phenotypes of gastric cancer. Cancers. 2022;14(6):1438.","journal-title":"Cancers"},{"issue":"6","key":"7244_CR87","doi-asserted-by":"publisher","first-page":"e930","DOI":"10.1002\/ctm2.930","volume":"12","author":"JY Sung","year":"2022","unstructured":"Sung JY, Cheong JH. Prognosis-related gene signature is enriched in cancer-associated fibroblasts in the stem-like subtype of gastric cancer. Clin Transl Med. 2022;12(6):e930.","journal-title":"Clin Transl Med"},{"issue":"1","key":"7244_CR88","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s11033-025-10748-0","volume":"52","author":"EW Tan","year":"2025","unstructured":"Tan EW, et al. Cancer stem cells: Mitochondria signalling pathway and strategies for therapeutic interventions. Mol Biol Rep. 2025;52(1):671.","journal-title":"Mol Biol Rep"},{"key":"7244_CR89","doi-asserted-by":"publisher","first-page":"1160440","DOI":"10.3389\/fphar.2023.1160440","volume":"14","author":"K Liang","year":"2023","unstructured":"Liang K. Mitochondrial CPT1A: Insights into structure, function, and basis for drug development. Front Pharmacol. 2023;14:1160440.","journal-title":"Front Pharmacol"},{"issue":"12","key":"7244_CR90","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/s43018-020-00126-z","volume":"1","author":"BM Stevens","year":"2020","unstructured":"Stevens BM, et al. Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells. Nat Cancer. 2020;1(12):1176\u201387.","journal-title":"Nat Cancer"},{"key":"7244_CR91","doi-asserted-by":"publisher","first-page":"102754","DOI":"10.1016\/j.redox.2023.102754","volume":"63","author":"H Jiang","year":"2023","unstructured":"Jiang H, et al. Drug-induced oxidative stress in cancer treatments: Angel or devil? Redox Biol. 2023;63:102754.","journal-title":"Redox Biol"},{"issue":"3","key":"7244_CR92","doi-asserted-by":"publisher","first-page":"270","DOI":"10.15283\/ijsc24060","volume":"17","author":"Y Park","year":"2024","unstructured":"Park Y, Jeong EM. Glutathione dynamics in the tumor microenvironment: A potential target of cancer stem cells and T cells. Int J Multiling STEM Cells. 2024;17(3):270\u201383.","journal-title":"Int J Multiling STEM Cells"},{"key":"7244_CR93","doi-asserted-by":"crossref","unstructured":"Wang L, et al. Targeting ferroptosis in cancer stem cells: a novel strategy to improve cancer treatment. Genes Dis. 2025;101678.","DOI":"10.1016\/j.gendis.2025.101678"},{"issue":"4","key":"7244_CR94","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.cmet.2013.03.002","volume":"17","author":"M Liesa","year":"2013","unstructured":"Liesa M, Shirihai OS. Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metab. 2013;17(4):491\u2013506.","journal-title":"Cell Metab"},{"key":"7244_CR95","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.3390\/cells11162518","volume":"11","author":"YE Liu","year":"2022","unstructured":"Liu YE, et al. An epigenetic role of mitochondria in cancer. Cells. 2022;11:2518. https:\/\/doi.org\/10.3390\/cells11162518.","journal-title":"Cells"},{"issue":"7","key":"7244_CR96","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1089\/scd.2009.0113","volume":"18","author":"V Kashyap","year":"2009","unstructured":"Kashyap V, et al. Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. STEM Cells Dev. 2009;18(7):1093\u2013108.","journal-title":"STEM Cells Dev"},{"issue":"2","key":"7244_CR97","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.molcel.2020.03.004","volume":"78","author":"SA Haws","year":"2020","unstructured":"Haws SA, et al. Methyl-metabolite depletion elicits adaptive responses to support heterochromatin stability and epigenetic persistence. Mol Cell. 2020;78(2):210\u201323.e8.","journal-title":"Mol Cell"},{"issue":"1","key":"7244_CR98","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12943-023-01899-4","volume":"22","author":"X Wu","year":"2023","unstructured":"Wu X, et al. Targeting MHC-I molecules for cancer: Function, mechanism, and therapeutic prospects. Mol Cancer. 2023;22(1):194.","journal-title":"Mol Cancer"},{"issue":"3","key":"7244_CR99","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.cmet.2016.07.002","volume":"24","author":"T TeSlaa","year":"2016","unstructured":"TeSlaa T, et al. \u03b1-ketoglutarate accelerates the initial differentiation of primed human pluripotent stem cells. Cell Metab. 2016;24(3):485\u201393.","journal-title":"Cell Metab"},{"issue":"1","key":"7244_CR100","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40170-017-0165-0","volume":"5","author":"R Vatrinet","year":"2017","unstructured":"Vatrinet R, et al. The \u03b1-ketoglutarate dehydrogenase complex in cancer metabolic plasticity. Cancer Metab. 2017;5(1):3.","journal-title":"Cancer Metab"},{"issue":"3","key":"7244_CR101","first-page":"727","volume":"10","author":"Y Han","year":"2020","unstructured":"Han Y, Liu D, Li L. PD-1\/PD-L1 pathway: Current researches in cancer. Am J Cancer Res. 2020;10(3):727\u201342.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"7244_CR102","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s42003-023-04615-6","volume":"6","author":"L Ghantous","year":"2023","unstructured":"Ghantous L, et al. The DNA damage response pathway regulates the expression of the immune checkpoint CD47. Commun Biol. 2023;6(1):245.","journal-title":"Commun Biol"},{"issue":"15","key":"7244_CR103","doi-asserted-by":"publisher","first-page":"e2412109","DOI":"10.1002\/advs.202412109","volume":"12","author":"X Lu","year":"2025","unstructured":"Lu X, et al. NAD(+) metabolism reprogramming drives SIRT1-dependent deacetylation inducing PD-L1 nuclear localization in cervical cancer. Adv Sci (Weinh). 2025;12(15):e2412109.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"7244_CR104","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s40425-018-0360-8","volume":"6","author":"RD Leone","year":"2018","unstructured":"Leone RD, Emens LA. Targeting adenosine for cancer immunotherapy. J Immunother Cancer. 2018;6(1):57.","journal-title":"J Immunother Cancer"},{"key":"7244_CR105","doi-asserted-by":"publisher","first-page":"813218","DOI":"10.3389\/fimmu.2022.813218","volume":"13","author":"J Zhu","year":"2022","unstructured":"Zhu J, et al. CD39\/CD73 dysregulation of adenosine metabolism increases decidual natural killer cell cytotoxicity: Implications in unexplained recurrent spontaneous abortion. Front Immunol. 2022;13:813218.","journal-title":"Front Immunol"},{"key":"7244_CR106","doi-asserted-by":"publisher","first-page":"1113739","DOI":"10.3389\/fnut.2023.1113739","volume":"10","author":"Z Li","year":"2023","unstructured":"Li Z, et al. Lactate in the tumor microenvironment: A rising star for targeted tumor therapy. Front Nutr. 2023;10:1113739.","journal-title":"Front Nutr"},{"key":"7244_CR107","doi-asserted-by":"publisher","first-page":"1573039","DOI":"10.3389\/fimmu.2025.1573039","volume":"16","author":"X Jin","year":"2025","unstructured":"Jin X, et al. Lactate-mediated metabolic reprogramming of tumor-associated macrophages: Implications for tumor progression and therapeutic potential. Front Immunol. 2025;16:1573039.","journal-title":"Front Immunol"},{"issue":"1","key":"7244_CR108","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41392-021-00499-2","volume":"6","author":"C Su","year":"2021","unstructured":"Su C, et al. The key roles of cancer stem cell-derived extracellular vesicles. Signal Transduct Target Ther. 2021;6(1):109.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"7244_CR109","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00262-020-02679-5","volume":"70","author":"Y Wang","year":"2021","unstructured":"Wang Y, et al. Tumor-selective blockade of CD47 signaling with a CD47\/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity. Cancer Immunol Immunother. 2021;70(2):365\u201376.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"7244_CR110","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41392-023-01365-z","volume":"8","author":"Y Liu","year":"2023","unstructured":"Liu Y, et al. Emerging phagocytosis checkpoints in cancer immunotherapy. Signal Transduct Target Ther. 2023;8(1):104.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"7244_CR111","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41420-025-02403-1","volume":"11","author":"Y Shi","year":"2025","unstructured":"Shi Y, Zhang H, Miao C. Metabolic reprogram and T cell differentiation in inflammation: Current evidence and future perspectives. Cell Death Discov. 2025;11(1):123.","journal-title":"Cell Death Discov"},{"key":"7244_CR112","doi-asserted-by":"crossref","unstructured":"Abu Shelbayeh O, et al. PGC-1\u03b1 is a master regulator of mitochondrial lifecycle and ROS stress response. Antioxid (basel). 2023;12(5).","DOI":"10.3390\/antiox12051075"},{"issue":"4","key":"7244_CR113","doi-asserted-by":"publisher","first-page":"159094","DOI":"10.1016\/j.bbalip.2021.159094","volume":"1867","author":"J Ji","year":"2022","unstructured":"Ji J, et al. NAD supplementation improves mitochondrial performance of cardiolipin mutants. Biochim Biophys Acta Mol Cell Biol Lipids. 2022;1867(4):159094.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"3","key":"7244_CR114","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.cmet.2018.02.011","volume":"27","author":"L Rajman","year":"2018","unstructured":"Rajman L, Chwalek K, Sinclair DA. Therapeutic potential of NAD-Boosting molecules: The in vivo evidence. Cell Metab. 2018;27(3):529\u201347.","journal-title":"Cell Metab"},{"issue":"1","key":"7244_CR115","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12943-024-02175-9","volume":"23","author":"M-Q Yang","year":"2024","unstructured":"Yang M-Q, et al. Targeting mitochondria: Restoring the antitumor efficacy of exhausted T cells. Mol Cancer. 2024;23(1):260.","journal-title":"Mol Cancer"},{"issue":"3","key":"7244_CR116","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3390\/cimb47030176","volume":"47","author":"C-J Liu","year":"2025","unstructured":"Liu C-J, Wang L-K, Tsai F-M. The application and molecular mechanisms of mitochondria-targeted antioxidants in chemotherapy-induced cardiac injury. Curr Issues Mol Biol. 2025;47(3):176.","journal-title":"Curr Issues Mol Biol"},{"issue":"6","key":"7244_CR117","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1007\/s00262-020-02795-2","volume":"70","author":"Q Li","year":"2021","unstructured":"Li Q, Ngo PT, Egilmez NK. Anti-PD-1 antibody-mediated activation of type 17 T-cells undermines checkpoint blockade therapy. Cancer Immunol Immunother. 2021;70(6):1789\u201396.","journal-title":"Cancer Immunol Immunother"},{"issue":"9","key":"7244_CR118","doi-asserted-by":"publisher","first-page":"e43879","DOI":"10.15252\/embr.201643879","volume":"19","author":"LF Costa-Machado","year":"2018","unstructured":"Costa-Machado LF, et al. Sirt1 protects from K-Ras-driven lung carcinogenesis. EMBO Rep. 2018;19(9):e43879.","journal-title":"EMBO Rep"},{"key":"7244_CR119","doi-asserted-by":"crossref","unstructured":"Salmond RJ. mTOR regulation of glycolytic metabolism in T Cells. Front Cell Dev Biol. 2018;6:- 2018.","DOI":"10.3389\/fcell.2018.00122"},{"issue":"1","key":"7244_CR120","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1038\/s41467-022-30396-3","volume":"13","author":"N Baran","year":"2022","unstructured":"Baran N, et al. Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia. Nat Commun. 2022;13(1):2801.","journal-title":"Nat Commun"},{"issue":"1","key":"7244_CR121","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1527-3466.2007.00006.x","volume":"25","author":"H Ashrafian","year":"2007","unstructured":"Ashrafian H, Horowitz JD, Frenneaux MP. Perhexiline. Cardiovasc Drug Rev. 2007;25(1):76\u201397.","journal-title":"Perhexiline. Cardiovasc Drug Rev"},{"issue":"1","key":"7244_CR122","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13046-018-0784-5","volume":"37","author":"M Yi","year":"2018","unstructured":"Yi M, et al. Emerging role of lipid metabolism alterations in cancer stem cells. J Exp Clin Cancer Res. 2018;37(1):118.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"7244_CR123","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13045-023-01498-2","volume":"16","author":"HR Jin","year":"2023","unstructured":"Jin HR, et al. Lipid metabolic reprogramming in tumor microenvironment: From mechanisms to therapeutics. J Hematol Oncol. 2023;16(1):103.","journal-title":"J Hematol Oncol"},{"issue":"7","key":"7244_CR124","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1007\/s00262-023-03430-6","volume":"72","author":"J Bendell","year":"2023","unstructured":"Bendell J, et al. First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors. Cancer Immunol Immunother. 2023;72(7):2443\u201358.","journal-title":"Cancer Immunol Immunother"},{"issue":"Pt 3","key":"7244_CR125","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1469-7793.1999.0633s.x","volume":"517","author":"C Juel","year":"1999","unstructured":"Juel C, Halestrap AP. Lactate transport in skeletal muscle - role and regulation of the monocarboxylate transporter. J Physiol. 1999;517(Pt 3):633\u201342.","journal-title":"J Physiol"},{"key":"7244_CR126","doi-asserted-by":"publisher","first-page":"1208870","DOI":"10.3389\/fimmu.2023.1208870","volume":"14","author":"H Tao","year":"2023","unstructured":"Tao H, et al. Unveiling the veil of lactate in tumor-associated macrophages: A successful strategy for immunometabolic therapy. Front Immunol. 2023;14:1208870.","journal-title":"Front Immunol"},{"issue":"6","key":"7244_CR127","first-page":"57","volume":"2","author":"J Kasznicki","year":"2014","unstructured":"Kasznicki J, Sliwinska A, Drzewoski J. Metformin in cancer prevention and therapy. Ann Transl Med. 2014;2(6):57.","journal-title":"Ann Transl Med"},{"issue":"10","key":"7244_CR128","doi-asserted-by":"publisher","first-page":"e1633235","DOI":"10.1080\/2162402X.2019.1633235","volume":"8","author":"S Verdura","year":"2019","unstructured":"Verdura S, et al. Metformin as an archetype immuno-metabolic adjuvant for cancer immunotherapy. Oncoimmunology. 2019;8(10):e1633235.","journal-title":"Oncoimmunology"},{"issue":"1","key":"7244_CR129","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13046-021-01847-4","volume":"40","author":"Y Yao","year":"2021","unstructured":"Yao Y, et al. What is the prospect of indoleamine 2, 3-dioxygenase 1 inhibition in cancer? Extrapolation from the past. J Exp Clin Cancer Res. 2021;40(1):60.","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"7244_CR130","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1158\/0008-5472.CAN-23-2742","volume":"84","author":"S Murphy","year":"2024","unstructured":"Murphy S, et al. Ketogenic diet alters the epigenetic and immune landscape of prostate cancer to overcome resistance to immune checkpoint blockade therapy. Cancer Res. 2024;84(10):1597\u2013612.","journal-title":"Cancer Res"},{"issue":"1","key":"7244_CR131","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3390\/biomedicines13010210","volume":"13","author":"Z Liang","year":"2025","unstructured":"Liang Z, et al. Comprehensive overview of ketone bodies in cancer metabolism: Mechanisms and application. Biomedicines. 2025;13(1):210.","journal-title":"Biomedicines"},{"issue":"3","key":"7244_CR132","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","volume":"167","author":"R Geiger","year":"2016","unstructured":"Geiger R, et al. L-Arginine modulates T cell metabolism and enhances survival and anti-tumor activity. Cell. 2016;167(3):829\u201342.e13.","journal-title":"Cell"},{"key":"7244_CR133","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-6481967\/v1","volume-title":"Spatially resolved panoramic in vivo CRISPR screen via perturb-DBiT","author":"R Fan","year":"2025","unstructured":"Fan R, et al. Spatially resolved panoramic in vivo CRISPR screen via perturb-DBiT. Res Sq; 2025."},{"key":"7244_CR134","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-4814866\/v1","volume-title":"Spatial dynamics of mammalian brain development and neuroinflammation by multimodal tri-omics mapping","author":"R Fan","year":"2024","unstructured":"Fan R, et al. Spatial dynamics of mammalian brain development and neuroinflammation by multimodal tri-omics mapping. Res Sq; 2024."},{"issue":"10","key":"7244_CR135","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1038\/s41587-023-01676-0","volume":"41","author":"Y Liu","year":"2023","unstructured":"Liu Y, et al. High-plex protein and whole transcriptome co-mapping at cellular resolution with spatial CITE-seq. Nat Biotechnol. 2023;41(10):1405\u201309.","journal-title":"Nat Biotechnol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07244-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07244-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07244-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:06:25Z","timestamp":1761743185000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07244-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":135,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7244"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07244-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"2 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"1190"}}